People don't talk enough about how big the YourBio acquisition is for $HIMS.
Hims Labs at first wasn't that special. Nice UI, easy results, and AI help — just conveniences.
The real game-changer? YourBio.
Preventative healthcare's biggest hurdle isn't access. It's fric
SpaceX's IPO is getting crazy — Reuters says investors have piled in with over $250 billion, making it 4x oversubscribed 😳
Friday is going to be wild 🚀
Before this sell-off, everyone was piling into large cap tech stocks. Like I always say, when the whole crowd is on one side of the boat, it's way easier to tip over.
Check out how the Magnificent 7 stocks did over the past 5 years:
Nvidia $NVDA +1,067%🚀
Apple $AAPL +144%📈
Google $GOOGL +208%📈
Microsoft $MSFT +66%📈
Amazon $AMZN +53%📈
Meta Platforms $META +80%📈
Tesla $TSLA +96%📈
Just in:
The S&P 500 just added 2 new stocks to the index:
Marvell $MRVL
Flex $FLEX
They join before markets open on June 22.
Pool Corp $POOL and Campbell's $CPB are getting dropped.
@backett987660 Lowering the bar that much is a smart move. More people getting a shot at early-stage stuff like this changes the whole game for retail investors.
@KS3666049181421 Honestly, most people overthink this. ROIC is cleaner for comparing internal performance, but ROCE can be a quick sanity check for capital-heavy sectors.
AI development costs are through the roof. Daniela Amodei from Anthropic says that's why companies like hers are turning to public markets for funding 💸